Cancer genes: rare recombinants instead of activated oncogenes (a review)
- PMID: 3550807
- PMCID: PMC304600
- DOI: 10.1073/pnas.84.8.2117
Cancer genes: rare recombinants instead of activated oncogenes (a review)
Abstract
The 20 known transforming (onc) genes of retroviruses are defined by sequences that are transduced from cellular genes termed protooncogenes or cellular oncogenes. Based on these sequences, viral onc genes have been postulated to be transduced cellular cancer genes, and proto-onc genes have been postulated to be latent cancer genes that can be activated from within the cell to cause virus-negative tumors. The hypothesis is popular because it promises direct access to cellular cancer genes. However, the existence of latent cancer genes presents a paradox, since such genes are clearly undesirable. The hypothesis predicts that viral onc genes and proto-onc genes are isogenic; that expression of proto-onc genes induces tumors; that activated proto-onc genes transform diploid cells upon transfection, like viral onc genes; and that diploid tumors exist. As yet, none of these predictions is confirmed. Instead: Structural comparisons between viral onc genes, essential retroviral genes, and proto-onc genes show that all viral onc genes are indeed new genes, rather than transduced cellular cancer genes. They are recombinants put together from truncated viral and truncated proto-onc genes. Proto-onc genes are frequently expressed in normal cells. To date, not one activated proto-onc gene has been isolated that transforms diploid cells. Above all, no diploid tumors with activated proto-onc genes have been found. Moreover, the probability of spontaneous transformation in vivo is at least 10(9) times lower than predicted from the mechanisms thought to activate proto-onc genes. Therefore, the hypothesis that proto-onc genes are latent cellular oncogenes appears to be an overinterpretation of sequence homology to structural and functional homology with viral onc genes. Here it is proposed that only rare truncations and illegitimate recombinations that alter the germ-line configuration of cellular genes generate viral and possibly cellular cancer genes. The clonal chromosome abnormalities that are consistently found in tumor cells are microscopic evidence for rearrangements that may generate cancer genes. The clonality indicates that the tumors are initiated with, and possibly by, these abnormalities, as predicted by Boveri in 1914.
Similar articles
-
Cancer genes generated by rare chromosomal rearrangements rather than activation of oncogenes.Med Oncol Tumor Pharmacother. 1987;4(3-4):163-75. doi: 10.1007/BF02934512. Med Oncol Tumor Pharmacother. 1987. PMID: 3326980 Review.
-
Latent cellular oncogenes: the paradox dissolves.J Cell Sci Suppl. 1987;7:169-87. doi: 10.1242/jcs.1987.supplement_7.13. J Cell Sci Suppl. 1987. PMID: 3332652
-
Cancer genes by illegitimate recombination.Ann N Y Acad Sci. 1989;567:259-73. doi: 10.1111/j.1749-6632.1989.tb16477.x. Ann N Y Acad Sci. 1989. PMID: 2679322 Review.
-
Unmutated proto-src coding region is tumorigenic if expressed from the promoter of Rous sarcoma virus: implications for the gene-mutation hypothesis of cancer.Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6393-7. doi: 10.1073/pnas.89.14.6393. Proc Natl Acad Sci U S A. 1992. PMID: 1321438 Free PMC article.
-
Activated proto-onc genes: sufficient or necessary for cancer?Science. 1985 May 10;228(4700):669-77. doi: 10.1126/science.3992240. Science. 1985. PMID: 3992240
Cited by
-
Illegitimate recombination induced by benzo[a]pyrene diol epoxide in Escherichia coli.Proc Natl Acad Sci U S A. 1988 Feb;85(4):1043-6. doi: 10.1073/pnas.85.4.1043. Proc Natl Acad Sci U S A. 1988. PMID: 3124112 Free PMC article.
-
Generation of fibrosarcomas in vivo by a retrovirus that expresses the normal B chain of platelet-derived growth factor and mimics the alternative splice pattern of the v-sis oncogene.Proc Natl Acad Sci U S A. 1989 Apr;86(8):2693-7. doi: 10.1073/pnas.86.8.2693. Proc Natl Acad Sci U S A. 1989. PMID: 2649890 Free PMC article.
-
Cellular aging is a critical determinant of primary cell resistance to v-src transformation.J Virol. 1997 Jan;71(1):237-47. doi: 10.1128/JVI.71.1.237-247.1997. J Virol. 1997. PMID: 8985343 Free PMC article.
-
Cancer genes generated by rare chromosomal rearrangements rather than activation of oncogenes.Med Oncol Tumor Pharmacother. 1987;4(3-4):163-75. doi: 10.1007/BF02934512. Med Oncol Tumor Pharmacother. 1987. PMID: 3326980 Review.
-
Utility of short-term tests for genetic toxicity.Cell Biol Toxicol. 1989 Jun;5(2):189-200. doi: 10.1007/BF00122652. Cell Biol Toxicol. 1989. PMID: 2670087 Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials